• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $MO

    Altria Group Inc.

    Subscribe to $MO
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, oral tobacco products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in transportation, power generation, real estate, and manufacturing equipment industries. The company sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

    IPO Year:

    Exchange: NYSE

    Website: altria.com

    Peers

    $PM

    Recent Analyst Ratings for Altria Group Inc.

    DatePrice TargetRatingAnalyst
    4/1/2025Buy → Hold
    Deutsche Bank
    1/16/2025$54.00Equal-Weight
    Morgan Stanley
    12/6/2024$55.00 → $65.00Neutral → Buy
    BofA Securities
    10/8/2024$44.50 → $48.00Neutral
    Citigroup
    1/23/2024Sell
    UBS
    4/14/2023$52.00Buy
    Stifel
    11/10/2022$38.00Neutral → Sell
    UBS
    6/29/2022$53.00 → $36.00Equal Weight → Underweight
    Barclays
    6/24/2022$47.00 → $43.00Underweight → Equal-Weight
    Morgan Stanley
    6/8/2022$54.00 → $50.00Equal-Weight → Underweight
    Morgan Stanley
    See more ratings

    Altria Group Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Davis Robert Matthews bought $48,599 worth of shares (1,200 units at $40.50), increasing direct ownership by 16% to 8,473 units (SEC Form 4)

      4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

      11/8/23 3:08:44 PM ET
      $MO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Clarke Ian L.T. bought $44,625 worth of shares (1,100 units at $40.57), increasing direct ownership by 18% to 7,145 units (SEC Form 4)

      4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

      11/8/23 3:03:21 PM ET
      $MO
      Medicinal Chemicals and Botanical Products
      Health Care

    Altria Group Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Altria Holds 2025 Annual Meeting of Shareholders; Declares Regular Quarterly Dividend of $1.02 Per Share

      Altria Group, Inc. (Altria) (NYSE:MO) held our 2025 Annual Meeting of Shareholders (Annual Meeting) today. During the Annual Meeting, Billy Gifford, Altria's Chief Executive Officer, addressed shareholder questions. A copy of the presentation and a replay of the webcast are available on www.altria.com. Preliminary Voting Results The preliminary voting results from our shareholders at the Annual Meeting were as follows: elected to a one-year term each of the 11 nominees for our Board of Directors (Board) named in our 2025 Proxy Statement; ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025; approved, on an advisory b

      5/15/25 1:30:00 PM ET
      $MO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Altria to Host Webcast of 2025 Annual Meeting of Shareholders

      Altria Group, Inc. (Altria) (NYSE:MO) will host a live audio webcast of its 2025 Annual Meeting of Shareholders ("2025 Annual Meeting" or "meeting") on Thursday, May 15, 2025 at 9:00 a.m. Eastern Time. The 2025 Annual Meeting will be held virtually via live webcast. During the meeting, shareholders as of the 2025 Annual Meeting record date (March 25, 2025) will be able to vote their shares electronically and will be able to submit questions during the meeting as time permits. Although shareholders will be able to vote their shares during the meeting, they are encouraged to do so before the meeting using one of the methods described in the 2025 Proxy Statement. If you are not a shareholder

      5/1/25 10:00:00 AM ET
      $MO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Altria Reports 2025 First-Quarter Results; Reaffirms Full-Year Guidance

      Altria Group, Inc. (NYSE:MO) today reports our 2025 first-quarter business results and reaffirms our guidance for 2025 full-year adjusted diluted earnings per share (EPS). "Our highly profitable traditional tobacco businesses performed well in a challenging environment in the first quarter," said Billy Gifford, Altria's Chief Executive Officer. "The smokeable products segment delivered solid adjusted operating companies income growth behind the strength of Marlboro. In the oral tobacco products segment, on! maintained momentum in a competitive marketplace as Helix invested strategically behind the brand. And shareholders continued to benefit from strong cash returns through dividends and s

      4/29/25 7:00:00 AM ET
      $MO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Altria to Host Webcast of 2025 First-Quarter Results

      Altria Group, Inc. (Altria) (NYSE:MO) will host a live audio webcast on Tuesday, April 29, 2025, at 9:00 a.m. Eastern Time to discuss its 2025 first-quarter business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com. During the webcast, Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Chief Financial Officer, will discuss the Company's 2025 first-quarter business results and answer questions from the investment community and news media. The webcast will be in a listen-only mode. Pre-event registration is necessary; directions are posted at www.

      4/15/25 10:00:00 AM ET
      $MO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Altria Declares Regular Quarterly Dividend of $1.02 Per Share

      Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.02 per share, payable on April 30, 2025 to shareholders of record as of March 25, 2025. The ex-dividend date is March 25, 2025. View source version on businesswire.com: https://www.businesswire.com/news/home/20250227441410/en/ Altria Client Services Investor Relations 804-484-8222 Altria Client Services Media Relations 804-484-8897 www.altria.com/contact-us/media

      2/27/25 3:00:00 PM ET
      $MO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2025 Full-Year Earnings Guidance

      Altria Group, Inc. (Altria) (NYSE:MO) is participating in the Consumer Analyst Group of New York Conference in Orlando, Florida today. Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Executive Vice President and Chief Financial Officer, will highlight our exciting progress toward our Vision, discuss how our traditional tobacco businesses continue to support our strategies and provide more detail on our long-term growth aspirations. "We believe our actions over time have positioned Altria to win in U.S. nicotine over the long term," said Billy Gifford. "We have a demonstrated commitment to responsibility, an extensive understanding of U.S. nicotine consumers and a

      2/19/25 7:00:00 AM ET
      $MO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Altria to Host Webcast From the Consumer Analyst Group of New York Conference

      Altria Group, Inc. (Altria) (NYSE:MO) will host a webcast of its business presentation at the annual Consumer Analyst Group of New York conference in Orlando, Florida, on Wednesday, February 19, 2025, at approximately 10:00 a.m. Eastern Time. The webcast will feature a presentation by Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Executive Vice President and Chief Financial Officer. The webcast will be in a listen-only mode. Pre-event registration is necessary; directions are posted at www.altria.com/webcasts. An archived copy of the webcast will be available on altria.com. View source version on businesswire.com: https://www.businesswire.com/news/home/2025

      2/5/25 10:00:00 AM ET
      $MO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Solaris Energy Infrastructure Announces the Addition of Max Yzaguirre to its Board of Directors

      Solaris Energy Infrastructure, Inc. (NYSE:SEI) ("Solaris" or the "Company") announced today that Mr. Max Yzaguirre has been named as an independent member of the Company's Board of Directors (the "Board"), effective January 30, 2025. With the addition of Mr. Yzaguirre, the Board is now composed of 10 members. "We are pleased to welcome Max to our Board and look forward to the value he will bring Solaris," said Bill Zartler, Solaris Chairman and Chief Executive Officer. "His experience developing energy and power related projects as well as his former roles as Chairman of the Texas Public Utility Commission and an ERCOT Board Member will provide unique insight to Solaris as we continue to

      1/30/25 6:39:00 PM ET
      $ARIS
      $MO
      $SEI
      $WAFD
      Oilfield Services/Equipment
      Energy
      Medicinal Chemicals and Botanical Products
      Health Care
    • Altria Announces Election of Richard S. Stoddart to Altria's Board of Directors

      Altria Group, Inc. (NYSE:MO) is pleased to announce that Richard S. Stoddart will join our Board of Directors (Board) on February 3, 2025. Mr. Stoddart has served as the board chair of Hasbro, Inc. (NASDAQ:HAS), a global play and entertainment company, since February 2022 and as a board member since 2014. He previously served as Hasbro's interim Chief Executive Officer (CEO) from October 2021 to February 2022, following the passing of Hasbro's former board chair and CEO. Mr. Stoddart is the former President and CEO of InnerWorkings, Inc., a global marketing execution firm, serving in that role from April 2018 until October 2020 when InnerWorkings, Inc. was acquired. Mr. Stoddart was the C

      1/30/25 7:01:00 AM ET
      $HAS
      $MO
      Recreational Games/Products/Toys
      Consumer Discretionary
      Medicinal Chemicals and Botanical Products
      Health Care
    • Altria Reports 2024 Fourth-Quarter and Full-Year Results; Provides 2025 Full-Year Earnings Guidance; Announces New $1 Billion Share Repurchase Program

      Altria Group, Inc. (NYSE:MO) today reports our 2024 fourth-quarter and full-year business results and provides our guidance for 2025 full-year adjusted diluted earnings per share (EPS). "2024 was another pivotal year for Altria, headlined by meaningful progress toward our Vision, strong financial results and significant cash returns to shareholders," said Billy Gifford, Altria's Chief Executive Officer. "Our companies' leading brands and talented teams enabled our core tobacco businesses to deliver solid income growth and margin expansion, while we strategically invested in our future." "We expect to deliver 2025 full-year adjusted diluted EPS in a range of $5.22 to $5.37. This range re

      1/30/25 7:00:00 AM ET
      $MO
      Medicinal Chemicals and Botanical Products
      Health Care